Abstract: New 5-(2-thienyl)-1,2,4-triazoles and 5-(2-thienyl)-1, 3,4-oxadiazoles namely, N-[3-mercapto-5-(2-thienyl)-1,2,4-triazol-4-yl]-N'-arylthioureas 4a-e, 2-arylamino-5-(2-thienyl)-1,2,4-triazolo [3,4-b][1,3,4]thiadiazoles 5a-e, 3-arylaminomethyl-5-(2-thienyl)-1,3,4-oxadiazoline-2-thiones 7a-e, 3-(N-substituted anilinomethyl)-5-(2-thienyl)-1,3,4-oxadiazoline-2-thiones 8a, b and 3-(4-substituted-1-piperazinylmethyl)-5-(2-thienyl)-1,3,4-oxadiazoline-2-thiones 9a-f, were prepared. The synthesized compounds were tested for in vitro activities against certain strains of Gram-positive and Gram-negative bacteria and the yeast-like pathogenic fungus Candida albicans. Compound 9a displayed marked broad spectrum antibacterial activity, while compounds 4d, 5e, 7b, 7c, 7d, 9b, 9c and 9d were highly active against the tested Gram-positive bacteria. None of the synthesized compounds were proved to be significantly active against Candida albicans.
Introduction
In the past decades, the problem of multidrug resistant microorganisms has reached on alarming level around the world, and the synthesis of new anti-infective compounds has become an urgent need for the treatment of microbial infections. The 1,2,4-triazole nucleus has been incorporated into a wide variety of therapeutically important agents, mainly displaying antimicrobial [1] [2] [3] [4] [5] and antiinflammatory activities [6] [7] [8] [9] . In addition, several 1,3,4-oxadiazole derivatives were reported to exhibit OPEN ACCESS good antimicrobial [10] [11] [12] [13] and anti-inflammatory activities [13] [14] [15] . Moreover, the thiophene nucleus was proven to constitute the active part of several biologically active compounds [16] [17] [18] [19] [20] . In view of these findings, and in continuation to our interest in the synthesis and biological activities 1,2,4-triazoles and 1,3,4-oxadiazoles [7, 12] , the present investigation describes the synthesis as potential antimicrobial agents of new series of 1,2,4-triazoles and 1,3,4-oxadiazoles bearing 2-thienyl moieties.
Results and Discussion

Chemistry
4-Amino-5-mercapto-3-(2-thienyl)-1,2,4-triazole (3), required as starting material, was prepared via treatment of an ethanolic potassium hydroxide solution of thiophene-2-carbohydrazide (1) with carbon disulphide to yield the intermediate dithiocarbazate 2, which was subsequently reacted with hydrazine to yield compound 3 [21] . It was reported that the nature of the reaction products of N-amino-1,2,4-triazoles with arylisothiocyanates was dependent on the reaction solvent and temperature [22, 23] . Molina and Tárraga [22] reported the formation of the N,N'-disubstituted thiourea derivatives upon carrying out the reaction in N,N-dimethylformamide (DMF) at room temperature for 24 h and the formation of the 2,5-disubstituted-1,2,4-triazolo [3,4-b] [1, 3, 4] thiadiazoles upon prolonged heating in DMF. On the other hand, carrying out the reaction under microwave irradiation in the absence of solvent yielded the corresponding 2,5-disubstituted-1,2,4-triazolo [3,4-b] [1, 3, 4] thiadiazoles in good yield [23] . Thus, compound 3 was reacted with phenyl-or substituted phenylisothiocyanates in DMF at room temperature for 24 h to yield the corresponding N,N'-disubstituted thiourea derivatives 4a-e in excellent yields (85-90%). Compounds 4a-e were successfully dehydrosulphurized to the corresponding 2-arylamino-5-(2-thienyl)-1,2,4-triazolo [3,4-b] [1, 3, 4] thiadiazole derivatives 5a-e in 92%-95% yields via exposure to microwave irradiation for 5 min (Scheme 1, Table 1 ). 5-(2-Thienyl)-1,3,4-oxadiazoline-2-thione (6) was prepared via the reaction of the hydrazide 1 with carbon disulphide and potassium hydroxide, in ethanol, followed by acidification, following the previously reported methods [24] [25] [26] . Treatment of 6 with formaldehyde solution and primary aromatic amines, N-substituted anilines or N-substituted piperazines in ethanol at room temperature afforded good yields of the corresponding N-Mannich derivatives 7a-e, 8a, b and 9a-f, respectively (Scheme 2, Table 1 ). The structures of the synthesized compounds were confirmed by elemental analyses, IR, 1 H-NMR, 13 C-NMR, and mass spectral data. 
Antimicrobial Testing
The newly synthesized compounds 4a-e, 5a-e, 7a-e, 8a, b and 9a-f were tested for their in vitro antimicrobial activity against a panel of standard strains of the Gram-positive bacteria (Staphylococcus aureus IFO 3060 and Bacillus subtilis IFO 3007), the Gram-negative bacteria (Escherichia coli IFO 3301 and Pseudomonas aeuroginosa IFO 3448), and the yeast-like pathogenic fungus Candida albicans IFO 0583. The primary screening was carried out using the agar disc-diffusion method [27] using Müller-Hinton agar medium. Sterile filter paper discs (8 mm diameter) were moistened with the test compound solution in dimethylsulphoxide of specific concentration 200 g/disc were carefully placed on the agar cultures plates that had been previously inoculated separately with the microorganisms. The plates were incubated at 37 °C, and the diameter of the growth inhibition zones were measured after 24 h in case of bacteria and 48 h in case of Candida albicans. The results of the preliminary antimicrobial testing of compounds 4a-e, 5a-e, 7a-e, 8a, b and 9a-f (200 g/disc), the antibacterial antibiotic Ampicillin trihydrate (100g/disc) and the antifungal drug clotrimazole (100g/disc) are shown in Table 2 . The results revealed that the majority of the synthesized compounds showed varying degrees of inhibition against the tested microorganisms. In general, the best activity was displayed by compounds 4d, 4e, 5e, 7b, 7c, 7d, 9a, 9b, 9c and 9d, and the Grampositive bacteria Bacillus subtilis is considered the most sensitive among the tested microorganisms. Compound 9a showed high broad-spectrum inhibitory activity against the tested microorganisms, while compounds 4d, 5e, 7b, 7c, 7d, 9b, 9c and 9d were selectively active against the Gram-positive bacteria (inhibition zone >15 mm). Moderate (inhibition zone 12-15 mm) or weak (inhibition zone 10-12 mm) antibacterial activity was observed for compounds 4a, 4b, 4c, 5b, 5c, 5d, 7a and 7e. Meanwhile, compounds 5a, 8a, 8b, 9e and 9f were inactive against the tested microorganisms. All the synthesized compounds were practically inactive against Candida albicans, compounds 9a, 9c and 9d produced weak activity relative to the antifungal drug clotrimazole. The minimal inhibitory concentration (MIC) for the most active compounds 4b, 4c, 4d, 4e, 5e, 7a, 7b, 7c, 7d, 9a, 9b. 9c and 9d against the same microorganism used in the primary screening was carried out using the microdilution susceptibility method in Müller-Hinton Broth and Sabouraud Liquid Medium [28] . The compounds, Ampicillin trihydrate and clotrimazole were dissolved in dimethylsulphoxide at concentration of 128 g/mL. The twofold dilutions of the solution were prepared (128, 64, 32, …, 0.5 g/mL). The microorganism suspensions at 10 6 CFU/mL (colony forming unit/mL) concentrations were inoculated to the corresponding wells. The plates were incubated at 36 °C for 24 and 48 h for the bacteria and Candida albicans, respectively. The MIC values were determined as the lowest concentration that completely inhibited visible growth of the microorganism as detected by unaided eye. The MIC of the most active compounds, the antibacterial antibiotic ampicillin trihydrate and the antifungal drug clotrimazole which are shown in Table 3 , were in accordance with the results obtained in the primary screening. The structure-antibacterial activity relationship of the synthesized compounds revealed that the acyclic N,N'-disubstituted thiourea derivatives 4a-e and their cyclic 2,5-disubstituted-1,2,4-triazolo [3,4-b] [1, 3, 4] thiadiazoles analogues 5a-e are almost of equal activity against the tested Grampositive bacteria and almost inactive against the Gram-negative bacteria. The antibacterial activity of the oxadiazole N-Mannich derivatives 7a-e, 8a, b and 9a-f indicated that antibacterial activity is mainly dependent on the aminomethyl substituents. The arylaminomethyl-1,3,4-oxadiazoline-2-thiones 7a-e were almost active against both the Gram-positive and Gram-negative bacteria, while N-methyl or benzyl derivatives 8a, b were completely inactive. Regarding the piperazine derivatives 9a-f, the methyl, phenyl, 4-fluorophenyl and 2-trifluoromethylphenyl derivatives 9a, 9b, 9c and 9d were highly active against the Gram-positive bacteria and to lesser extent to the Gram-negative bacteria. On the other hand, replacement of the methyl or aryl substituents in compounds 9a, 9b, 9c and 9d with a 4-benzyl-or 2-trifluoromethylbenzyl moieties 9e and 9f dramatically reduced the antimicrobial activity. None of the synthesized compounds were found to be active against Candida albicans, and only the piperazine derivatives 9a, 9c and 9d exhibited marginal activities.
Experimental
General
All melting points (°C, uncorrected) were determined using a Gallenkamp melting point apparatus. Microwave irradiation was performed using an Akai MW-GB092MP (800 W) unmodified domestic microwave oven operated at 2450 MHz. Infra red spectra were recorded in KBr disc using Jasco FT/IR 460 Plus spectrometer, and expressed in wave number υ (cm
−1
). NMR spectra were obtained on a Bruker AC 500 Ultra Shield NMR spectrometer at 500 MHz for 1 H and 125 MHz for 13 C, the chemical shifts are expressed in  (ppm) downfield from tetramethylsilane (TMS). Electron impact mass spectra were recorded on a Shimadzu GC-MS-QP 5000 instrument. Elemental analyses (C, H, N, S) were in full agreement with the proposed structures within ±0.4% of the theoretical values. The bacterial strains and Candida albicans fungus were obtained from the Institute of fermentation of Osaka (IFO), Osaka, Japan. The reference drugs ampicillin trihydrate (CAS 7177-48-2) and clotrimazole (CAS 23593-75-1) were purchased from Sigma-Aldrich Chemie GmbH (Taufkirchen, Germany).
N-[3-Mercapto-5-(2-thienyl)-1,2,4-triazol-4-yl]-N'-arylthioureas 4a-e
The appropriate arylisothio-cyanate (2 mmol) was added to a solution of 4-amino-3-mercapto-5-(2-thienyl)-1,2,4-triazole (3, 0.4 g, 2 mmol) in dry DMF (8 mL), and the solution was stirred at room temperature for 24 h. Water (20 mL) was then added and the mixture was stirred for 20 min. The separated precipitate was filtered, washed with water and crystallized from ethanol. 
4a: IR, υ (cm
2-Arylamino-5-(2-thienyl)-1,2,4-triazolo[3,4-b][1,3,4]thiadiazoles 5a-e
The appropriate N,N'-disubstituted thiourea 4a-c (2 mmol) was placed in 50 mL open round bottom flask, and the mixture was irradiated in the microwave oven for 5 min. at 454 W (58%). On cooling, chloroform (10 mL) was added and the reaction mixture was stirred for 5 min., then filtered and the filtrate was evaporated in vacuo. The crude product was crystallized to yield the desired compounds 5a-e. 5a: IR, υ (cm (2-thienyl)-1,3,4-oxadiazoline-2-thiones 7a-e, 3-(N-substituted  anilinomethyl)-5-(2-thienyl)-1,3,4-oxadiazoline-2-thiones 8a,b and 3-(4-substituted-1-piperazinylmethyl)-5-(2-thienyl)-1,3,4 -oxadiazoline-2-thiones 9a-f he appropriate primary aromatic amine, N-substituted aniline or 1-substituted piperazine (2 mmol) and 37% formaldehyde solution (0.5 mL) were added to a solution of 5-(2-thienyl)-1,3,4-oxadiazoline-2-thione (6, 0.37 g, 2 mmol) in ethanol (8 mL), and the mixture was stirred at room temperature for 2 h and allowed to stand overnight. The separated precipitate was filtered, washed with cold ethanol, dried, and crystallized. 
3-Arylaminomethyl-5-
